JB

Joshua Browder

CEO at DoNotPay (we’re hiring!) - MIT Technology Review 35 Under 35

United States

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $1,000,000.00

Work Experience

2015

  • Founder and CEO

    2015

    DoNotPay is the A.I. consumer champion, automating consumer rights. The company is backed by an investment from Andreessen Horowitz, Coatue, Index Ventures, Founders Fund, Felicis and Greylock Partners. It has saved consumers an estimated $100 million and now works in hundreds of legal areas. The company has been featured in every major media outlet internationally, including the Wall Street Journal, BBC News, Guardian, CBC, Telegraph, Business Insider, ITV, TechCrunch, Daily Mail, NPR, Bloomberg, NBC, ABC, CBS 'This Morning', Telemundo and others. The BBC nicknames it, "the Robin Hood of the Internet." The company is currently valued at $210m; however, we are fortunate to be highly profitable and issue dividends to our investors and employees, one of the first "VC backed companies," to do so.

  • Solo GP

    2020

    Run a preseed fund focused on talented founders in my network (Stanford, Thiel Fellowship, among others). Fortunate to be invested in over 33 Thiel Fellows, including 45% (9/20) of the class of 2023! My fund is backed by Sequoia Capital, Marc Andreessen and leading fund of funds (Cendana).

2019

  • Pre-Seed Investor and First Believer

    2019

2021

  • Pre-Seed Investor and First Believer

    2021

2022

  • Pre-Seed Investor, First Believer and Board Member

    2022

2020

  • Pre-Seed Investor and First Believer

    2020

2023

  • Pre-Seed Investor

    2023

2022

  • Pre-seed Investor

    2022

2017 - 2018

  • Greylock Partners - EIR Intern

    2017 - 2018

    Worked on DoNotPay.

  • Research Fellow (Economics)

    2015 - 2015

    Worked with Professor Kuziemko and Fisman on programming a tool to investigate the question: "why do people think taxing the rich is unfair?" The research was ultimately published in 'The New York Times'

Latest Articles